Self-Injection of DMPA-SC Leads to Improved Continuation Rates

Can we help you find something?
Advocacy & Awareness
Beyond 2020
Contraceptive Security
ECHO Study
FP in Humanitarian Settings
Financing
Innovation
Policy and Enabling Environment
Rights
Service Delivery & Quality
Young People
Commitment Maker
Country
Commitment Maker
Country
Self-Injection of DMPA-SC Leads to Improved Continuation Rates
Publication Date: 09/29/2017

Injectable contraceptives are among the most popular family planning options. They are safe, effective, and discreet, but in many countries women in rural and remote communities often travel long distances to reach clinics that offer injectable contraceptives.

At the request of the Malawi Ministry of Health and USAID/Malawi, FHI 360, through the U.S. Agency for International Development’s Advancing Partners & Communities project, conducted a randomized controlled trial comparing continuation rates of women who self-injected DMPASC and women who received DMPA-SC from a provider, including CHWs.

Tags
Resource Type:
Partners:
USAID
Source:
FHI360